Millbrae, California, United States
Key technologies and capabilities for this role
Common questions about this position
The role requires a minimum of 3 days a week of onsite presence (or more as business needs require) in either our California or New Jersey offices to ensure effective management, operational excellence, and team collaboration.
A minimum of global clinical operational experience is required, along with expertise in therapeutic and clinical drug development, FDA Regulations, ICH-GCP, EMA, PMDA, and other relevant regulations.
The role involves team leadership and building, managing clinical trial deliverables, timelines, and budgets, hiring, performance management, career development, and mentorship of Clinical Study Management personnel, with minimal oversight.
The culture emphasizes collaboration, solutions-oriented mindset, flexibility, passion for excellence in advancing patient care, cross-functional teamwork, operational excellence, and high-performance delivery amid significant team growth.
Strong candidates are collaborative, solutions-oriented, flexible individuals with global clinical operational experience, team leadership skills, and expertise in clinical study execution and regulatory compliance in oncology.
Biotech startup developing innovative medicines
Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that aim to improve and extend life. A key feature of Eikon's approach is their proprietary single-molecule tracking (SMT) platform, which enables rapid visualization of protein movements in living cells. This technology, along with artificial intelligence and automation, allows for precise inventorying of molecular interactions. Eikon Therapeutics targets patients with serious diseases who need effective treatments, generating revenue through the development and commercialization of their therapies.